Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LivTech is a biotechnology and medical device company dedicated to developing advanced therapies for patients suffering from acute and chronic liver failure. The company's core technology is a bioartificial liver support system designed to provide temporary metabolic support and detoxification, bridging patients to transplant or allowing the native liver to regenerate. By integrating proprietary cell-based components with sophisticated filtration hardware, LivTech aims to address the critical shortage of donor organs and improve survival rates in life-threatening hepatic conditions. The company is currently advancing its lead programs through clinical evaluation to establish safety and efficacy in high-need patient populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LivTech.